Advances in the allostery of angiotensin II type 1 receptor

Angiotensin II type 1 receptor (AT1R) is a promising therapeutic target for cardiovascular diseases. Compared with orthosteric ligands, allosteric modulators attract considerable attention for drug development due to their unique advantages of high selectivity and safety. However, no allosteric modu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xi, Zhang, Suli, Wang, Meili, Chen, Hao, Liu, Huirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276441/
https://www.ncbi.nlm.nih.gov/pubmed/37330563
http://dx.doi.org/10.1186/s13578-023-01063-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276441/
https://www.ncbi.nlm.nih.gov/pubmed/37330563
http://dx.doi.org/10.1186/s13578-023-01063-x

Ejemplares similares